Trying to see whether the increase in tau-pathology under 3NP involves the regulation of GSK, the key kinase which is involved in the phosphorylation of tau in AD/tauopathy related epitopes, we indeed detected alterations in the enzyme level and its phosphorylated state. Here, MAPT is linked to Alzheimer disease.